FAB: Clinical trials of Omega-3 for depression

UK Nutrient Gaps and Impacts on Early Development with Dr Emma Derbyshire and TC Callis - BOOK HERE

Clinical trials of Omega-3 for depression - Research

Berger G et al 2026 - Ï‰-3 Fatty Acids in Pediatric Major Depressive Disorder: A Randomized Clinical Trial
Li S et al 2025 - Omega-3 supplementation improves depressive symptoms, cognitive function and niacin skin flushing response in adolescent depression: A randomized controlled clinical trial
Campisi et al 2024 - Omega-3 fatty acid supplementation for depression in children and adolescents
Wu et al 2024 - The Efficacy of Omega-3 Fatty Acids as the Monotherapy for Depression: A Randomized, Double-Blind, Placebo-Controlled Pilot Study
Norouziasl R et al 2024 - Efficacy and safety of n-3 fatty acids supplementation on depression: a systematic review and dose-response meta-analysis of randomised controlled trials
Lu Y et al 2023 - Clinical impacts of n-3 fatty acids supplementation on depression symptoms: an umbrella review of meta-analyses
Chang J P C et al 2023 - Omega-3 polyunsaturated fatty acids (n-3 PUFAs), somatic and fatigue symptoms in cardiovascular diseases comorbid major depressive disorder (MDD): A randomized controlled trial
Kelaiditis et al 2023 - Effects of long-chain omega-3 polyunsaturated fatty acids on reducing anxiety and/or depression in adults; A systematic review and meta-analysis of randomised controlled trials
Mischoulon D et al 2022 - Omega-3 Fatty Acids for Major Depressive Disorder With High Inflammation: A Randomized Dose-Finding Clinical Trial
Appleton et al 2021 - Omega-3 fatty acids for depression in adults
Bozzatello P et al 2021 - Mental Health in Childhood and Adolescence: The Role of Polyunsaturated Fatty Acids
Saunders E et al 2021 - Adjunctive dietary intervention for bipolar disorder: a randomized, controlled, parallel-group, modified double-blinded trial of a high n-3 plus low n-6 diet
Borsini A et al 2021 - Omega-3 polyunsaturated fatty acids protect against inflammation through production of LOX and CYP450 lipid mediators: relevance for major depression and for human hippocampal neurogenesis
Karaszewska D et al 2021 - Marine Omega-3 Fatty Acid Supplementation for Borderline Personality Disorder
Madison A et al 2021 - Omega-3 supplementation and stress reactivity of cellular aging biomarkers: an ancillary substudy of a randomized, controlled trial in midlife adults
Zhang et al 2020 - The efficacy and safety of omega-3 fatty acids on depressive symptoms in perinatal women: a meta-analysis of randomized placebo-controlled trials
Luo et al 2020 - High-dose omega-3 polyunsaturated fatty acid supplementation might be more superior than low-dose for major depressive disorder in early therapy period: a network meta-analysis
Chang J P C et al 2020 - Omega-3 polyunsaturated fatty acids in cardiovascular diseases comorbid major depressive disorder - Results from a randomized controlled trial
Bai et al 2019 - Efficacy and safety of anti-inflammatory agents for the treatment of major depressive disorder
Firth et al 2019 - The efficacy and safety of nutrient supplements in the treatment of mental disorders

Food and Behaviour Research is a registered charity (No SC034604) and a company limited by guarantee (Co No SC 253448)

Newsletter Signup

Useful Links

Contact Us

FAB Research
23 Carlton Road
Oxford
OX2 7SA

Important Notice

Medical opinion and guidance should always be sought for any symptoms that might possibly reflect a known or suspected disease, disorder or medical condition. Information provided on this website (or by FAB Research via any other means) does not in any way constitute advice on the treatment of any medical condition formally diagnosed or otherwise.